6
Oct
2026

Laboratorios Salvat, S.A.

Exhibitor at CPHI Milan 2026 stand 16F33, Finished Dosage & Formulation
About Us

SALVAT is a pharmaceutical company headquartered in Barcelona with a subsidiary in Miami. SALVAT develops, manufactures, and markets high-quality pharmaceuticals in otorhinolaryngology, gastroenterology, ophthalmology, and consumer healthcare. We offer licensing of our products, contract manufacturing and development services (in Spain and USA) in ophthalmic, otic and oral formulations.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Spain
  • On CPHI since:
    2016
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Drug delivery device Supplier/Manufacturer
Licensee
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16F33, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    Product SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    SVT-15473 is the first strongest ophthalmic corticosteroid formulated in nanoemulsion (nanodroplets below ~30nm), using IMPACT-SVT®, a patented drug delivery technology, and in single-dose vials, using Blow-Fill-Seal technology packaging.

    SVT-15473 has&nbs...
  • Clotic®- Otic Fungal Infection - Otic Rx

    Product Clotic®- Otic Fungal Infection - Otic Rx

    Clotic® is a broad-spectrum otic antimycotic agent effective against pathogenic dermatophytes, yeasts and several species of fungus. Well-recognized safety and efficacy.
    The first and only treatment with clinical evidence against otomycosis. Preservative-free.

    Indication: Otic fu...
  • Ophthalmic CDMO Services

    Product Ophthalmic CDMO Services

    Salvat offers the best services and solutions, drawing on a long history of expertise in developing and manufacturing successful medications.

    Tailored solutions to customer needs through our Ophthalmic platform: • • Customized solutions using Salvat's technology: suspensions, solutions, micellar,...
  • Contract Development & Manufacturing Services (CDMO)

    Product Contract Development & Manufacturing Services (CDMO)

    With 70 years of experience in developing and manufacturing pharmaceutical products for diverse markets, we excel in Operational Excellence, Flexibility, and Adaptability.

    Salvat offers integrated CDMO services with state-of-the-art manufacturing facilities in Barcelona, Madrid, and Miami, equip...
  • Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO

    Product Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO

    Salvat specializes in developing and manufacturing sterile liquid pharmaceutical products in single-dose vials using Blow-Fill-Seal (BFS) technology.

    Advantages of using Blow-Fill-Seal technology in your products: 
    • • Innovative format, providing differentiation for your produ...

Laboratorios Salvat, S.A. Resources (1)

  • SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Video SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.

    IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.

    2023-11-22